Skip to main content
logo
LIR Life Sciences Corp. (CSE:SKNY)
Canada flag Canada · Delayed Price · Currency is CAD
0.1350
-0.0050 (-3.57%)
At close: Oct 29, 2026

LIR Life Sciences Ratios and Metrics

Millions CAD. Fiscal year is May - Apr.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Oct '26 Apr '26 Apr '25 Apr '24
Market Capitalization
415--
Market Cap Growth
----
Enterprise Value
414--
Last Close Price
0.140.55--

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Oct '26 Apr '26 Apr '25 Apr '24
PB Ratio
55.1223.35--
P/TBV Ratio
55.1223.35--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Oct '26 Apr '26 Apr '25 Apr '24
Debt / Equity Ratio
----7.06
Net Debt / Equity Ratio
-2.87-0.911.470.00
Net Debt / EBITDA Ratio
0.050.17--
Quick Ratio
1.263.680.600.88
Current Ratio
1.294.640.600.88
Return on Equity (ROE)
--1357.83%--
Return on Assets (ROA)
-1247.97%-447.87%-162.64%-
Return on Capital Employed (ROCE)
-6092.70%-522.80%516.10%300.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Oct '26 Apr '26 Apr '25 Apr '24
Earnings Yield
-135.32%-25.44%--
Buyback Yield / Dilution
-154.80%-331.53%-41648.94%-